HOUSE BILL 289

Sponsored By:

Delegate Feldman

Entitled:

Economic Development - Maryland Stem Cell Research Act - Revisions

Synopsis:

Altering the name of the Stem Cell Research Commission to be the Stem Cell and Biotechnologies Commercialization Commission; requiring the Commission to establish procedures and guidelines regarding research supporting a qualified technology; altering the name of the Maryland Stem Cell Research Fund to be the Maryland Stem Cell and Biotechnologies Commercialization Fund; altering the purpose of the Fund so as to support innovative biotechnology research and development that has the potential to create job growth; etc.

History by Legislative and Calendar Date

House Action

1/27

First Reading Health and Government Operations & Economic Matters

2/1

Hearing 2/7 at 1:30 p.m. (Health and Government Operations)

3/6

Unfavorable Report by Health and Government Operations Withdrawn

Senate Action

No Action

Bill indexed under the following Subjects:

Commerce and Business -see also- Dealers; Elec. Comm.; etc

Committees and Commissions -see also- Political Committees

Genetics

Grants

Industry and Technology

Loans -see also- Mortgages

Medical Research

Names

Reports

Revenue and Taxes -see also- Dev Fees &Taxes; specific tax

Bill affects the following Statutes:

Economic Development

( 10-429 , 10-430 , 10-431 , 10-432 , 10-434 through 10-436 , 10-437 through 10-441 , 10-442 )

Documents

Bill Text: First Reading, Third Reading, Enrolled

Fiscal and Policy Note: Available

Amendments: None offered

Committee Votes :

House

Economic Matters

Health and Government Operations